219 related articles for article (PubMed ID: 16918348)
1. Cellular mechanisms and prospective applications of hypericin in photodynamic therapy.
Kiesslich T; Krammer B; Plaetzer K
Curr Med Chem; 2006; 13(18):2189-204. PubMed ID: 16918348
[TBL] [Abstract][Full Text] [Related]
2. Hypericin in cancer treatment: more light on the way.
Agostinis P; Vantieghem A; Merlevede W; de Witte PA
Int J Biochem Cell Biol; 2002 Mar; 34(3):221-41. PubMed ID: 11849990
[TBL] [Abstract][Full Text] [Related]
3. St John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell death.
Kleemann B; Loos B; Scriba TJ; Lang D; Davids LM
PLoS One; 2014; 9(7):e103762. PubMed ID: 25076130
[TBL] [Abstract][Full Text] [Related]
4. Characterization of apoptosis induced by photodynamic treatment with hypericin in A431 human epidermoid carcinoma cells.
Berlanda J; Kiesslich T; Oberdanner CB; Obermair FJ; Krammer B; Plaetzer K
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):173-88. PubMed ID: 16566716
[TBL] [Abstract][Full Text] [Related]
5. Hypericin lights up the way for the potential treatment of nasopharyngeal cancer by photodynamic therapy.
Olivo M; Du HY; Bay BH
Curr Clin Pharmacol; 2006 Sep; 1(3):217-22. PubMed ID: 18666746
[TBL] [Abstract][Full Text] [Related]
6. In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin.
Seitz G; Krause R; Fuchs J; Heitmann H; Armeanu S; Ruck P; Warmann SW
Oncol Rep; 2008 Nov; 20(5):1277-82. PubMed ID: 18949433
[TBL] [Abstract][Full Text] [Related]
7. Hypericin-assisted photodynamic therapy against anaplastic thyroid cancer.
Kim H; Kim SW; Seok KH; Hwang CW; Ahn JC; Jin JO; Kang HW
Photodiagnosis Photodyn Ther; 2018 Dec; 24():15-21. PubMed ID: 30118906
[TBL] [Abstract][Full Text] [Related]
8. Hypericin--a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules.
Miskovsky P
Curr Drug Targets; 2002 Feb; 3(1):55-84. PubMed ID: 11899265
[TBL] [Abstract][Full Text] [Related]
9. Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
Höpfner M; Maaser K; Theiss A; Lenz M; Sutter AP; Kashtan H; von Lampe B; Riecken EO; Zeitz M; Scherübl H
Int J Colorectal Dis; 2003 May; 18(3):239-47. PubMed ID: 12673490
[TBL] [Abstract][Full Text] [Related]
10. Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria.
Miccoli L; Beurdeley-Thomas A; De Pinieux G; Sureau F; Oudard S; Dutrillaux B; Poupon MF
Cancer Res; 1998 Dec; 58(24):5777-86. PubMed ID: 9865736
[TBL] [Abstract][Full Text] [Related]
11. The pro-apoptotic and anti-invasive effects of hypericin-mediated photodynamic therapy are enhanced by hyperforin or aristoforin in HT-29 colon adenocarcinoma cells.
Šemeláková M; Mikeš J; Jendželovský R; Fedoročko P
J Photochem Photobiol B; 2012 Dec; 117():115-25. PubMed ID: 23099482
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer resistance protein is the enemy of hypericin accumulation and toxicity of hypericin-mediated photodynamic therapy.
Jendželovský R; Jendželovská Z; Kuchárová B; Fedoročko P
Biomed Pharmacother; 2019 Jan; 109():2173-2181. PubMed ID: 30551474
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo activation of hypericin with the incoherent light source PDT 1200 SOA (520-750 nm) and with solar simulated radiation (290-2500 nm).
Schempp CM; Simon-Haarhaus B; Heine A; Schöpf E; Simon JC
Photodermatol Photoimmunol Photomed; 1999 Feb; 15(1):13-7. PubMed ID: 9990663
[TBL] [Abstract][Full Text] [Related]
14. Time-resolved gene expression profiling of human squamous cell carcinoma cells during the apoptosis process induced by photodynamic treatment with hypericin.
Sanovic R; Krammer B; Grumboeck S; Verwanger T
Int J Oncol; 2009 Oct; 35(4):921-39. PubMed ID: 19724930
[TBL] [Abstract][Full Text] [Related]
15. Hypericin--the facts about a controversial agent.
Kubin A; Wierrani F; Burner U; Alth G; Grünberger W
Curr Pharm Des; 2005; 11(2):233-53. PubMed ID: 15638760
[TBL] [Abstract][Full Text] [Related]
16. Differential cytotoxic effects induced after photosensitization by hypericin.
Vandenbogaerde AL; Cuveele JF; Proot P; Himpens BE; Merlevede WJ; de Witte PA
J Photochem Photobiol B; 1997 Apr; 38(2-3):136-42. PubMed ID: 9203374
[TBL] [Abstract][Full Text] [Related]
17. A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy.
Lavie G; Kaplinsky C; Toren A; Aizman I; Meruelo D; Mazur Y; Mandel M
Br J Cancer; 1999 Feb; 79(3-4):423-32. PubMed ID: 10027308
[TBL] [Abstract][Full Text] [Related]
18. The multifaceted photocytotoxic profile of hypericin.
Theodossiou TA; Hothersall JS; De Witte PA; Pantos A; Agostinis P
Mol Pharm; 2009; 6(6):1775-89. PubMed ID: 19739671
[TBL] [Abstract][Full Text] [Related]
19. Hypericin-loaded lipid nanocapsules for photodynamic cancer therapy in vitro.
Barras A; Boussekey L; Courtade E; Boukherroub R
Nanoscale; 2013 Nov; 5(21):10562-72. PubMed ID: 24056802
[TBL] [Abstract][Full Text] [Related]
20. Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells.
Ali SM; Olivo M
Int J Oncol; 2002 Sep; 21(3):531-40. PubMed ID: 12168096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
